North American Study for the Treatment of Refractory Ascites (NASTRA)

Completed · Phase 3

Conditions studied: Ascites, Liver Cirrhosis

In brief

The NASTRA Clinical Trial is a multi-center, randomized, controlled clinical trial designed to determine if treatment with transjugular intrahepatic portasystemic shunts (TIPS) is superior to high volume paracentesis (total paracentesis, TP) for the treatment of refractory ascites due to cirrhosis. Only patients with clinically tense symptomatic ascites (shortness of breath, umbilical hernia, abdominal pain and/or distension, and/or limitation of activity) who have either diuretic-resistant ascites or diuretic-intractable ascites are being studied.

Key facts

Study ID
NCT00006166
Run by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Starts
1997-03-01
Expected to finish
2001-10-01
Last updated by the study team
2010-01-13

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.